Israeli COVID-19 Vaccine Developer Begins Phase II Trial In Georgia
The BriLife jabs arrived in Georgia over the weekend to begin the trial, which will run simultaneously with trials in Israel.
August 15, 2021
Israeli COVID-19 Vaccine Developer Inks Deal To Complete Trials, Commercialize Jab
The BriLife vaccine will be tested in Phase II and III trials in Georgia, Ukraine, and Israel as part of a deal with NRx Pharmaceuticals.
July 13, 2021
Israeli COVID-19 Vaccine Cleared For 2nd Phase Of Clinical Trial With 1,000 Volunteers
The 1st phase for the Israeli vaccine, with 80 volunteers, was completed successfully with no significant side effects.
December 15, 2020
Israeli Bio-Defense Lab Says It Found An Antibody That ‘Neutralizes’ The Coronavirus
The Israel Institute for Biological Research (IIBR) announced that it completed a 'groundbreaking scientific development' toward a potential COVID-19 treatment.
May 05, 2020